Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2–21 years …

S Sadeghi, Y Kalantari, S Shokri, M Fallahpour… - Journal of Clinical …, 2022 - Elsevier
… Additional data related to dosage of vaccines, antibody titers, type of assay for antibody
titration, and the relationship between time of vaccination and immunogenicity were reported in …

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

AI Yasin, SG Aydin, B Sümbül, L Koral, M Şimşek… - Future …, 2022 - Taylor & Francis
antibody tests compared with those who had negative antibody tests, suggesting a protective
effect of antibodies … Another study demonstrated that the antibody titers were correlated with …

Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: a randomized clinical trial

…, H Yoon, KS Goldfeld, AB Troxel… - JAMA internal …, 2022 - jamanetwork.com
… binding antibody titer and neutralizing titer, (2) CCP and participant SARS-CoV-2 antibody
profiles and … We report CCP and participant plasma antibody titers (analysis 1) and effects of …

Three-year efficacy and safety of Takeda's dengue vaccine candidate (TAK-003)

L Rivera, S Biswal, X Sáez-Llorens… - Clinical Infectious …, 2022 - academic.oup.com
… Participants were classified as seropositive when demonstrating a reciprocal neutralizing
antibody titer ≥ 10 against at least 1 dengue serotype at baseline. Cases of severe VCD were …

[HTML][HTML] A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 …

A Lasagna, F Agustoni, E Percivalle, S Borgetto… - ESMO open, 2021 - Elsevier
… against SARS-CoV-2 in terms of antibody titer (value and geometric mean) and specific T-…
-spike IgG antibodies after the full course of BNT162b2 vaccine, but their antibody titers were …

[HTML][HTML] Efficacy and safety of an Ad26. RSV. preF–RSV preF protein vaccine in older adults

AR Falsey, K Williams, E Gymnopoulou… - … England Journal of …, 2023 - Mass Medical Soc
… After vaccination, RSV A2 neutralizing antibody titers increased by a factor of 12.1 from
baseline to day 15, a finding consistent with other immunogenicity measures. Percentages of …

[HTML][HTML] Predicting Efficacies of Fractional Doses of Vaccines by Using Neutralizing Antibody Levels: Systematic Review and Meta-Analysis

Z Du, C Liu, Y Bai, L Wang, WW Lim… - JMIR Public Health …, 2024 - publichealth.jmir.org
… In this study, we first investigated the relationship between neutralizing antibody titers … ,
efficacy, and safety of fractional doses as of December 2021, indicating that they would be safe

Antibody responses in COVID-19: a review

M Chvatal-Medina, Y Mendez-Cortina… - Frontiers in …, 2021 - frontiersin.org
… shown controversial results in terms of safety and efficacy, and due to the variable immune
response among individuals, measuring antibody titers before transfusion is mostly required. …

Rapidly declining SARS-CoV-2 antibody titers within 4 months after BNT162b2 vaccination

DH Jo, D Minn, J Lim, KD Lee, YM Kang, KW Choe… - Vaccines, 2021 - mdpi.com
… The efficacy and safety of the BNT162b2 vaccine are known, … that the antibody and neutralizing
antibody titers increased … Overall, the antibody and neutralizing antibody titers tended …

A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured …

M Akova, S Unal - Trials, 2021 - Springer
… seroconversion rate, the seropositivity rate, neutralizing antibody titer, and IgG levels 14 days
after each dose of vaccination. The primary safety endpoint is the severity and frequency of …